Position in AZN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$263,571
-$10,564 QoQ
Shares Held
1,390
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,096
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAS Wealth Partners, Inc. holds $43,360,679 across 8 Drug Manufacturers - General names. AZN ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,858 | $13,023,412 | |
| 2 | JNJ |
Johnson & Johnson
|
41,193 | $10,461,786 | |
| 3 | ABBV |
AbbVie Inc.
|
32,676 | $8,222,588 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,241 | $5,556,468 | |
| 5 | AMGN |
Amgen Inc
|
12,997 | $4,706,473 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,426 | $715,986 | |
| 7 | PFE |
Pfizer Inc
|
17,043 | $410,395 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
1,390 | $263,571 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $263,571 | 1,390 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $274,135 | 1,390 | Shares | Sole | 2026-06-10 | |
| No filing history on record for this holder in this stock. | ||||||